Maria Fardis

Insider Reports History

Entity
Individual
Location
C/O Parmacyclics, Inc., 995 East Arques Avenue, Sunnyvale, CA
Signature
/s/ AJ Silver, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Maria Fardis:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CRISPR Therapeutics AG Director Stock Option (Right to Buy) 13K May 30, 2024 Direct

Insider Reports Filed by Maria Fardis

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CRSP CRISPR Therapeutics AG May 30, 2024 1 $0 4 May 31, 2024 Director
CRSP CRISPR Therapeutics AG Jun 8, 2023 1 $0 4 Jun 9, 2023 Director
CRSP CRISPR Therapeutics AG Jun 9, 2022 1 $0 4 Jun 10, 2022 Director
CRSP CRISPR Therapeutics AG Jun 9, 2022 0 $0 3 Jun 10, 2022 Director